Abstract

BackgroundIn this study, we designed a new (Su’S) target area delineation to protect the normal liver during liver regeneration and prospectively evaluate liver regeneration after radiotherapy, as well as to explore the clinical factors of liver regeneration and established a model and nomogram.MethodsThirty patients treated with preoperative downstaging radiotherapy were prospectively included in the training cohort, and 21 patients treated with postoperative adjuvant radiotherapy were included in the validation cohort. The cut-off points of each optimal predictor were obtained using receiver-operating characteristic analysis. A model and nomogram for liver regeneration after radiotherapy were developed and validated.ResultsAfter radiotherapy, 12 (40%) and 13 (61.9%) patients in the training and validation cohorts experienced liver regeneration, respectively. The risk stratification model based on the cutoffs of standard residual liver volume spared from at least 20 Gy (SVs20 = 303.4 mL/m2) and alanine aminotransferase (ALT=43 u/L) was able to effectively discriminate the probability of liver regeneration. The model and nomogram of liver regeneration based on SVs20 and ALT showed good prediction performance (AUC=0.759) in the training cohort and performed well (AUC=0.808) in the validation cohort.ConclusionsSVs20 and ALT were optimal predictors of liver regeneration. This model may be beneficial to the constraints of the normal liver outside the radiotherapy-targeted areas.

Highlights

  • Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related deaths worldwide [1]

  • The risk stratification model based on the cutoffs of standard residual liver volume spared from at least 20 Gy (SVs20 = 303.4 mL/m2) and alanine aminotransferase (ALT=43 u/L) was able to effectively discriminate the probability of liver regeneration

  • The model and nomogram of liver regeneration based on SVs20 and alanine transaminase (ALT) showed good prediction performance (AUC=0.759) in the training cohort and performed well (AUC=0.808) in the validation cohort

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related deaths worldwide [1]. In the past, regarding the clinical practice of radiotherapy for liver cancer, more attention has been paid to the prevention and treatment of radiation-induced liver injury [13,14,15], but no indepth study on liver regeneration has been conducted. In this study, we designed a new target area delineation to protect the normal liver of liver regeneration and prospectively evaluate liver regeneration after preoperative and postoperative radiotherapy, and further explored the clinical factors and established a model and nomogram for liver regeneration after radiotherapy for HCC. We designed a new (Su’S) target area delineation to protect the normal liver during liver regeneration and prospectively evaluate liver regeneration after radiotherapy, as well as to explore the clinical factors of liver regeneration and established a model and nomogram

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call